Our #1 favorite Psychedelics company Numinus Wellness (TSXV: NUMI) is up 10.17% today to a new three-month high of $0.325 per share.
On November 3rd, Oregon residents will be voting on a measure to create a program for legally administering psilocybin products, such as psilocybin-producing mushrooms to individuals aged 21 years or older. Click here to learn more about Oregon Measure 109!
NUMI has begun cultivating Psilocybe mushrooms, for the purpose of psilocybin production, at its 7000 square-foot Health Canada licensed facility. After industry bellwether Compass Pathways (CMPS), which now has a market cap of $1.52 billion, we consider NUMI to be the highest quality psychedelics company.
NUMI’s vertically integrated ecosystem positions it to be a first-in-market, trusted leader in the delivery of psychedelic-assisted psychotherapies when regulated!
Past performance is not an indicator of future returns. Psychstocks is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. The parent company of Psychstocks has been compensated by NUMI USD$30,000 cash for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.